Highlights

Most impactful activities

SWG Sessions at the EHA Congress 2025

Session title: Lymphoma treatment – When to start, when to stop and how to judge outcomes

Chair: Igor Aurer (HR)

Speakers:

  • Josée Zijlstra (NL) – Judging risk prediction and response by imaging – Lugano criteria (and beyond)
  • Natacha Bolanos (ES) – What is really important for the patient
  • Georg Hess (DE) – Integrating information, making judgements and avoiding pitfalls -all in a day’s work of a clinician

Session title: EHA-JSH Joint Symposium: Genomics of Lymphoma

Chairs: Catherine Akifumi Takaori-Kondo (JP)

Speakers:

  • Yasunori Kogure (JP) – Adult T-cell leukemia / lymphomas
  • Thomas Oellerich (DE) – Genomic data DLBCL

EHA-ESMO guideline partnership

The guidelines on HIV-related lymphomas and primary CNS lymphomas were published. Guidelines on other lymphoma types are being developed; some are expected to be published in 2025 and some in 2026.

European affairs

In collaboration with the EHA European Affairs Committee, the EHA LyG nominated experts to advise regulatory agencies on different items related to diagnosis and treatment of lymphoid malignancies.

All guidelines will undergo regular review and renewal.

Share